Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Farrow

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Nature Communications|September 12, 2013
Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicityAndrew J Nicoll, Silvia Panico, Darragh B Freir, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical StudiesJoshua S Alford, John W Lampe, Dorothy Brach, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Substituted pyrazoles as novel sEH antagonist: investigation of key binding interactions within the catalytic domainHo Yin Lo, Chuk C Man, Roman W Fleck, et al.
Iscience|November 7, 2022
Processes in DNA damage response from a whole-cell multi-omics perspectiveJames C Pino, Alexander L R Lubbock, Leonard A Harris, et al.
Nature Communications|June 10, 2011
Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sitesDarragh B Freir, Andrew J Nicoll, Igor Klyubin, et al.
Journal of Hospital Medicine|December 8, 2016
The Johns Hopkins Venous Thromboembolism Collaborative: Multidisciplinary team approach to achieve perfect prophylaxisMichael B Streiff, Brandyn D Lau, Deborah B Hobson, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) regionHo Yin Lo, Peter A Nemoto, Jin Mi Kim, et al.
PLOS Global Public Health|October 24, 2023
The South African breast cancer and HIV outcomes study: Profiling the cancer centres and cohort characteristics, diagnostic pathways, and treatment approachesWitness Mapanga, Oluwatosin A Ayeni, Wenlong Carl Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisRoy Lardenoije, Angela R S Kruse, Lukasz G Migas, et al.
Breast Cancer Research and Treatment|June 14, 2021
Impact of HIV infection on overall survival among women with stage IV breast cancer in South AfricaYoanna S Pumpalova, Oluwatosin A Ayeni, Wenlong Carl Chen, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Nature Communications|September 12, 2013
Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicityAndrew J Nicoll, Silvia Panico, Darragh B Freir, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical StudiesJoshua S Alford, John W Lampe, Dorothy Brach, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Substituted pyrazoles as novel sEH antagonist: investigation of key binding interactions within the catalytic domainHo Yin Lo, Chuk C Man, Roman W Fleck, et al.
Iscience|November 7, 2022
Processes in DNA damage response from a whole-cell multi-omics perspectiveJames C Pino, Alexander L R Lubbock, Leonard A Harris, et al.
Nature Communications|June 10, 2011
Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sitesDarragh B Freir, Andrew J Nicoll, Igor Klyubin, et al.
Journal of Hospital Medicine|December 8, 2016
The Johns Hopkins Venous Thromboembolism Collaborative: Multidisciplinary team approach to achieve perfect prophylaxisMichael B Streiff, Brandyn D Lau, Deborah B Hobson, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) regionHo Yin Lo, Peter A Nemoto, Jin Mi Kim, et al.
PLOS Global Public Health|October 24, 2023
The South African breast cancer and HIV outcomes study: Profiling the cancer centres and cohort characteristics, diagnostic pathways, and treatment approachesWitness Mapanga, Oluwatosin A Ayeni, Wenlong Carl Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisRoy Lardenoije, Angela R S Kruse, Lukasz G Migas, et al.
Breast Cancer Research and Treatment|June 14, 2021
Impact of HIV infection on overall survival among women with stage IV breast cancer in South AfricaYoanna S Pumpalova, Oluwatosin A Ayeni, Wenlong Carl Chen, et al.
Pageof 24